(December 5, 2017, 11:48 AM EST) -- ALEXANDRIA, Va. — In a Dec. 4 petition for inter partes review (IPR), a bovine reproductive technology company argues to the Patent Trial and Appeal Board that using sex-sorted sperm to produce two or more embryos of a desired sex is unpatentable pursuant to Sections 102 and 103 of the Patent Act, 35 U.S.C. §§ 102, 103 (Trans Ova Genetics LC v. XY LLC, No. IPR2018-00249, PTAB)....